Research programme: selective androgen receptor modulators - QuatRx Pharmaceuticals
Alternative Names: SARMs - QuatRx PharmaceuticalsLatest Information Update: 04 Apr 2008
At a glance
- Originator QuatRx Pharmaceuticals
- Class
- Mechanism of Action Selective androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Andropause
Most Recent Events
- 04 Apr 2008 Discontinued - Preclinical for Andropause in Finland (unspecified route)
- 16 May 2005 Hormos Medical has been acquired and merged into QuatRx Pharmaceuticals
- 11 Jul 2001 Preclinical development for Andropause in Finland (Unknown route)